Amylyx Pharmaceuticals, Inc.盘中异动大幅下跌5.04%报14.52美元

市场透视10-22

北京时间2025年10月22日23时22分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价快速下跌5.04%。截至发稿，该股报14.52美元/股，成交量38.0762万股，换手率0.36%，振幅6.15%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-41.44百万美元，每股收益-0.46美元，毛利-141000.00美元，市盈率-5.85...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2577531604?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-10-22 23:22","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2577531604","market":"us","top_or_hot":-1,"title":"Amylyx Pharmaceuticals, Inc.盘中异动 大幅下跌5.04%报14.52美元","media":"市场透视","content":"<div>\n<p>北京时间2025年10月22日23时22分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价快速下跌5.04%。截至发稿，该股报14.52美元/股，成交量38.0762万股，换手率0.36%，振幅6.15%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-41.44百万美元，每股收益-0.46美元，毛利-141000.00美元，市盈率-5.85...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022232207a46ed25e&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amylyx Pharmaceuticals, Inc.盘中异动 大幅下跌5.04%报14.52美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmylyx Pharmaceuticals, Inc.盘中异动 大幅下跌5.04%报14.52美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-22 23:22 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022232207a46ed25e&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年10月22日23时22分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价快速下跌5.04%。截至发稿，该股报14.52美元/股，成交量38.0762万股，换手率0.36%，振幅6.15%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-41.44百万美元，每股收益-0.46美元，毛利-141000.00美元，市盈率-5.85...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022232207a46ed25e&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AMLX","symbol_name":"Amylyx Pharmaceuticals","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022232207a46ed25e&s=b","article_id":"2577531604","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022232207a46ed25e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2577531604","pubTimestamp":1761146527,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年10月22日23时22分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.04%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"AMLX":"Amylyx Pharmaceuticals","BK4007":"制药"},"translate_title":"Amylyx Pharmaceuticals, Inc. fell 5.04% to $14.52 in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMLX":1.5},"content_text":"北京时间2025年10月22日23时22分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价快速下跌5.04%。截至发稿，该股报14.52美元/股，成交量38.0762万股，换手率0.36%，振幅6.15%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-41.44百万美元，每股收益-0.46美元，毛利-141000.00美元，市盈率-5.85倍。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Adaptimmune Therapeutics Plc、Engene Holdings Inc C/Wts 31/10/2028 (To Pur Com) Cl A、Cytomed Therapeutics Limited涨幅较大，Adaptimmune Therapeutics Plc、Rani Therapeutics Holdings, Inc.、Minerva Neurosciences, Inc较为活跃，换手率分别为121.96%、47.44%、34.53%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 (To Pur Com)、Rani Therapeutics Holdings, Inc.，振幅分别为83.54%、62.77%、34.91%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。公司有一个运营分部，即研究和开发针对神经退行性疾病和内分泌疾病的疗法业务。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2577531604","isCrawlerRequest":true}

Amylyx Pharmaceuticals, Inc.盘中异动 大幅下跌5.04%报14.52美元

精彩评论

Amylyx Pharmaceuticals, Inc.盘中异动大幅下跌5.04%报14.52美元